Exemestane may be another first-line, adjuvant therapy for hormone-receptor positive, early-stage breast cancer
Thursday, December 9, 2010 - 12:02
in Health & Medicine
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.